Bristol-Myers Squibb Company:企業の戦略・SWOT・財務情報

◆英語タイトル:Bristol-Myers Squibb Company - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4431
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:69
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Bristol-Myers Squibb Company – Strategy, SWOT and Corporate Finance Report
Summary

Bristol-Myers Squibb Company – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Bristol-Myers Squibb Company (BMS or ‘the company’) is a global biopharmaceutical company. The company is involved in the discovery, development, licensing, manufacturing, marketing, distribution and sale of innovative medicines in various therapeutic areas that primarily include cardiovascular; virology, oncology, and immunoscience. The company’s major brands include Baraclude, Sustiva, Reyataz, Opdivo, Eliquis, Orencia, Sprycel, Yervoy and Empliciti. The company operates across the Americas, Europe, Asia, Australia, and other regions of the world. BMS is headquartered in New York City, New York.

Scope

- Detailed information on Bristol-Myers Squibb Company required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Bristol-Myers Squibb Company in the form of a SWOT analysis
- An in-depth view of the business model of Bristol-Myers Squibb Company including a breakdown and examination of key business segments
- Intelligence on Bristol-Myers Squibb Company’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Bristol-Myers Squibb Company, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Bristol-Myers Squibb Company and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Bristol-Myers Squibb Company as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Bristol-Myers Squibb Company’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Bristol-Myers Squibb Company: Company Overview 9
Bristol-Myers Squibb Company: Overview and Key Facts 9
Bristol-Myers Squibb Company: Overview 9
Bristol-Myers Squibb Company: Key Facts 9
Bristol-Myers Squibb Company: Key Employees 11
Bristol-Myers Squibb Company: Key Employee Biographies 13
Bristol-Myers Squibb Company: Major Products and Services 19
Bristol-Myers Squibb Company: Company History 20
Bristol-Myers Squibb Company: Management Statement 32
Bristol-Myers Squibb Company: Locations and Subsidiaries 35
Bristol-Myers Squibb Company: Key Competitors 36
Bristol-Myers Squibb Company: Company Analysis 37
Bristol-Myers Squibb Company: Business Description 37
Bristol-Myers Squibb Company: SWOT Analysis 39
Bristol-Myers Squibb Company: SWOT Overview 39
Bristol-Myers Squibb Company: Strengths 39
Bristol-Myers Squibb Company: Weaknesses 40
Bristol-Myers Squibb Company: Opportunities 41
Bristol-Myers Squibb Company: Threats 42
Bristol-Myers Squibb Company: Corporate Financial Deals Activity 44
Bristol-Myers Squibb Company: Financial Deals Overview 44
Bristol-Myers Squibb Company: Targets and Partners 46
Bristol-Myers Squibb Company: Top Deals 2014 – 2018YTD* 51
Bristol-Myers Squibb Company: Advisors 52
Bristol-Myers Squibb Company: Top Legal Advisors 52
Bristol-Myers Squibb Company: Mergers and Acquisitions 53
Bristol-Myers Squibb Company: Corporate Venturing 54
Bristol-Myers Squibb Company: Partnership 55
Bristol-Myers Squibb Company: Divestments 56
Bristol-Myers Squibb Company: Recent Developments 57
Bristol-Myers Squibb Company: News and Events Summary 57
Bristol-Myers Squibb Company: Contracts 61
Bristol-Myers Squibb Company: Corporate Governance 62
Bristol-Myers Squibb Company: Financial Deals 63
Bristol-Myers Squibb Company: Financial Performance 63
Bristol-Myers Squibb Company: Grants 63
Bristol-Myers Squibb Company: Market Developments 64
Bristol-Myers Squibb Company: Regulatory and Legal Events 65
Bristol-Myers Squibb Company: Research & Development 66
Appendix 67
Contact Us 67
Methodology 67
About MarketLine 68

List of Tables
Table 1: Bristol-Myers Squibb Company: Key Facts
Table 2: Bristol-Myers Squibb Company: Key Employees
Table 3: Bristol-Myers Squibb Company: Locations and Subsidiaries
Table 4: Bristol-Myers Squibb Company: Key Competitors
Table 5: Bristol-Myers Squibb Company: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Bristol-Myers Squibb Company: M&A Activity by Geography (TTM*)
Table 7: Bristol-Myers Squibb Company: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Bristol-Myers Squibb Company: M&A Average Deal Size - Value (US$m)
Table 9: Bristol-Myers Squibb Company: Targets and Partners
Table 10: Bristol-Myers Squibb Company: Top Deals 2014 - 2018YTD*
Table 11: Bristol-Myers Squibb Company: Legal Advisor Ranking by Value (US$m)
Table 12: Bristol-Myers Squibb Company: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Bristol-Myers Squibb Company: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Bristol-Myers Squibb Company: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 15: Bristol-Myers Squibb Company: Corporate Venturing by Geography (2014 - YTD*2018)
Table 16: Bristol-Myers Squibb Company: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 17: Bristol-Myers Squibb Company: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 18: Bristol-Myers Squibb Company: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 19: Bristol-Myers Squibb Company: News and Events Summary
Table 20: Bristol-Myers Squibb Company: Contracts
Table 21: Bristol-Myers Squibb Company: Corporate Governance
Table 22: Bristol-Myers Squibb Company: Financial Deals
Table 23: Bristol-Myers Squibb Company: Financial Performance
Table 24: Bristol-Myers Squibb Company: Grants
Table 25: Bristol-Myers Squibb Company: Market Developments
Table 26: Bristol-Myers Squibb Company: Regulatory and Legal Events
Table 27: Bristol-Myers Squibb Company: Research & Development

List of Figures
Figure 1: Bristol-Myers Squibb Company: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Bristol-Myers Squibb Company: M&A Activity by Geography (TTM*)
Figure 3: Bristol-Myers Squibb Company: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Bristol-Myers Squibb Company: M&A Average Deal Size - Value (US$m)
Figure 5: Bristol-Myers Squibb Company: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Bristol-Myers Squibb Company: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Bristol-Myers Squibb Company: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: Bristol-Myers Squibb Company: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: Bristol-Myers Squibb Company: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 10: Bristol-Myers Squibb Company: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 11: Bristol-Myers Squibb Company: Divestments Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[Bristol-Myers Squibb Company:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • OSE Immunotherapeutics (OSE):企業の財務・戦略的SWOT分析
    Summary OSE Immunotherapeutics (OSE), formerly OSE Pharma SA, is a biotechnology company that discovers and develops immunotherapy products against invasive and metastatic late-stage cancers. The company’s memopi technology is employed in studying the development of treatments for ovarian, colon and …
  • Agfa-Gevaert N.V. (AGFB):企業の財務・戦略的SWOT分析
    Agfa-Gevaert N.V. (AGFB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Mizuho Trust & Banking Co Ltd:企業の戦略・SWOT・財務分析
    Mizuho Trust & Banking Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Mizuho Trust & Banking Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Fitbit Inc.:戦略・SWOT・企業財務分析
    Fitbit Inc. - Strategy, SWOT and Corporate Finance Report Summary Fitbit Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Kathmandu Holdings Limited:企業の戦略・SWOT・財務情報
    Kathmandu Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Kathmandu Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Radico Khaitan Ltd.:企業の戦略・SWOT・財務分析
    Radico Khaitan Ltd. - Strategy, SWOT and Corporate Finance Report Summary Radico Khaitan Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Phoenix Global Resources Plc (PGR):企業の財務・戦略的SWOT分析
    Phoenix Global Resources Plc (PGR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Sekisui House, Ltd.:企業の戦略・SWOT・財務情報
    Sekisui House, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sekisui House, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Exxon Mobil Corp (XOM):石油・ガス:M&Aディール及び事業提携情報
    Summary Exxon Mobil Corp (ExxonMobil) is an integrated oil and gas company that explores for and produces crude oil and natural gas; manufactures petroleum products; transports and sells crude oil and petroleum products; and markets natural gas and natural gas liquids. It is a major manufacturer and …
  • Savannah Petroleum Plc (SAVP):石油・ガス:M&Aディール及び事業提携情報
    Summary Savannah Petroleum Plc (Savannah Petroleum) is an oil and gas company. The company explores, appraises, develops, and produces conventional oil deposits. It operates principal assets in the R1/R2 and R3/R4 PSC areas of the Agadem Rift Basin in South East Niger. Savannah Petroleum blocks cove …
  • Indivumed GmbH:医療機器:M&Aディール及び事業提携情報
    Summary Indivumed GmbH (Indivumed) is an oncology company that provides solutions for diagnosis and treatment of cancer. The company is involved in the generation, characterization, and analysis of biologic samples from human cancer patients. It offers biospecimen products and clinical data sets; an …
  • Marshall of Cambridge (Holdings) Ltd:企業の戦略・SWOT・財務情報
    Marshall of Cambridge (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report Summary Marshall of Cambridge (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Air Methods Corp:企業の戦略的SWOT分析
    Air Methods Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • McCarthy Building Companies Inc:企業の戦略的SWOT分析
    McCarthy Building Companies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Gfk SE (GFK):企業の財務・戦略的SWOT分析
    Summary GfK SE (GfK) is a business service provider that offers market and consumer services. The company provides solutions such as online pricing intelligence, brand and customer experience, point of sales analytics, digital marketing intelligence, consumer panels, product catalogs, market opportu …
  • Rapid Pathogen Screening Inc-医療機器分野:企業M&A・提携分析
    Summary Rapid Pathogen Screening Inc (Rapid Pathogen) is a biotechnology company that designs, develops, manufactures and markets point-of-care diagnostic tests. The company uses its patented direct sampling micro-filtration and direct multi-planar chromafiltography technology to develop various tes …
  • Constellium NV:企業の戦略・SWOT・財務情報
    Constellium NV - Strategy, SWOT and Corporate Finance Report Summary Constellium NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Qiagen Marseille SA-製薬・医療分野:企業M&A・提携分析
    Summary Qiagen Marseille SA (HalioDx), formerly Ipsogen SA is a subsidiary of Qiagen NV, a drugs manufacturing company that develops and markets molecular diagnostic tests. The company offers products for the treatment of chronic myeloid, chronic lymphocytic, acute myeloid, and acute lymphoblastic l …
  • CohBar Inc (COB.U):企業の財務・戦略的SWOT分析
    Summary CohBar Inc (CohBar) is a developer of mitochondria based therapeutics. The company develops a class of drugs to treat a wide range of diseases associated with aging and metabolic dysfunction such as non-alcoholic steatohepatitis, obesity, type 2 diabetes, cancer, cardiovascular disease and C …
  • Oil India Ltd (OIL):石油・ガス:M&Aディール及び事業提携情報
    Summary Oil India Ltd (OIL) is an integrated upstream petroleum company which explores, develops, and produces crude oil and natural gas. It has petroleum exploration licenses in India; and exploration and production blocks across Venezuela, Gabon, Myanmar, Nigeria, Libya, Mozambique, Bangladesh, th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆